C21 Investments Inc. (CSE:CXXI)
Canada · Delayed Price · Currency is CAD 0.3850
-0.0100 (-2.53%)
At close: Feb 27, 2026
C21 Investments Revenue
C21 Investments had revenue of $8.14M USD in the quarter ending December 31, 2025, with 2.95% growth. This brings the company's revenue in the last twelve months to $33.27M, up 24.19% year-over-year. In the fiscal year ending March 31, 2025, C21 Investments had annual revenue of $30.12M with 12.42% growth.
Revenue (ttm)
$33.27M
Revenue Growth
+24.19%
P/S Ratio
1.00
Revenue / Employee
$241.09K
Employees
138
Market Cap
45.44M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 30.12M | 3.33M | 12.42% |
| Mar 31, 2024 | 26.79M | -1.50M | -5.29% |
| Jan 31, 2024 | 28.29M | -603.21K | -2.09% |
| Jan 31, 2023 | 28.89M | -4.09M | -12.41% |
| Jan 31, 2022 | 32.98M | -483.09K | -1.44% |
| Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| iAnthus Capital Holdings | 209.79M |
| Planet 13 Holdings | 151.05M |
| Decibel Cannabis Company | 109.31M |
| Vext Science | 66.63M |
| Rubicon Organics | 57.19M |
| MediPharm Labs | 46.10M |
| Leef Brands | 45.21M |
| LSL Pharma Group | 26.80M |